BioSpace News Archive

Adimab, LLC today announced that 12 new partner programs entered clinical development in 2023.

Axena Health, Inc. has signed agreements with four leading distributors to streamline access to the Leva® Pelvic Health System.

Milla Pharmaceuticals Inc., an A.forall company, announced that its partner, Woodward Pharma Services LLC, has just commercialized its Supplemental Abbreviated New Drug Application approval from the U.S. Food and Drug Administration for a generic version of Sodium Acetate Injection 4 mEq/mL marketed by Fresenius Kabi USA LLC.

Critical Path Institute announced that Klaus Romero, M.D., M.S., FCP, has been named its new Chief Executive Officer.

Mitochon Pharmaceuticals today announced that it was awarded approval from EMA to begin enrollment for a Phase I/IIa biomarker study in Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Huntington’s Disease (HD) and Alzheimer’s Disease (AD) participants.

Alveo Technologies, Inc. announced it is working with experts and leaders in the poultry industry to launch a rapid, accurate, in-the-field multiplex panel to test for all relevant strains of avian influenza, initially focusing on Group A, H5, H7, and H9.

Kymera Therapeutics, Inc. today announced the closing of its upsized underwritten public offering of $275 million of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock.

Extreme weather conditions and power outages are especially common in the winter season. Continue reading to learn more about how to keep your food safe during an emergency.

Alnylam Pharmaceuticals, Inc. said that Chief Executive Officer Yvonne Greenstreet has been selected as the 2024 Woman of the Year by the Healthcare Businesswomen’s Association.

Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”)